Published in Int J Radiat Oncol Biol Phys on August 01, 1979
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79
Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol (1995) 2.80
A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. J Pediatr (1972) 2.48
Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol (1998) 1.88
Small cell carcinoma of the bladder and prostate. Urology (1995) 1.81
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol (1995) 1.71
De novo muscle invasive bladder cancer: is there a change in trend? J Urol (2001) 1.54
Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol (1994) 1.51
Transitional cell carcinoma of the prostate. J Urol (1991) 1.47
Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology (1999) 1.44
Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer. Cancer (1992) 1.44
Radioimmunoassay of ovine luteinizing hormone in PVC disposable trays using a cutting aid. Med Lab Sci (1977) 1.42
Does pericapsular lignocaine reduce pain during transrectal ultrasonography-guided biopsy of the prostate? BJU Int (2003) 1.38
How architecture wins technology wars. Harv Bus Rev (1993) 1.38
Patients' choice of treatment in stage D prostate cancer. Urology (1989) 1.34
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients. Cancer (1995) 1.34
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res (1997) 1.28
Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr (1969) 1.24
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group. Urology (1995) 1.23
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol (2000) 1.22
Rationale for intensive intravesical chemotherapy for superficial bladder cancer. J Urol (1980) 1.21
Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer (1984) 1.21
Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol (1999) 1.18
Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology (1996) 1.18
Update on bladder neck preservation during radical retropubic prostatectomy: impact on pathologic outcome, anastomotic strictures, and continence. Urology (1998) 1.17
Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer (1980) 1.15
Complications of advanced prostate cancer. Urology (1999) 1.13
Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8. BJU Int (2003) 1.13
Panoramic radiographic survey: a study of embedded third molars. J Oral Surg (1971) 1.12
Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. J Urol (2001) 1.09
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep (1980) 1.09
Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer (1991) 1.08
Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res (1977) 1.07
Hexachlorobenzene episode in Turkey. Biomed Environ Sci (1989) 1.06
Ileal conduit exfoliative cytology in the diagnosis of recurrent cancer. J Urol (1972) 1.05
Pitressin-resistant hyposthenuria in chronic renal disease. Am J Med (1967) 1.05
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Image distortion in rotational panoramic radiography. I. General considerations. Acta Radiol Diagn (Stockh) (1981) 1.03
The effect of mitomycin C on superficial bladder cancer. J Urol (1981) 1.03
Quality of life 12 months after radical prostatectomy. Br J Urol (1995) 1.02
Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer. J Urol (2000) 1.01
Improved detection of recurrent bladder cancer using the Bard BTA stat Test. Urology (1997) 1.00
Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol (2001) 0.98
Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med (1995) 0.98
Prostate cancer after heart transplantation. J Urol (1995) 0.97
Image distortion in rotational panoramic radiography. III. Inclined objects. Acta Radiol Diagn (Stockh) (1981) 0.97
Susceptibility of urothelium to neoplastic cellular implantation. Urology (1975) 0.96
Selecting initial therapy for bladder cancer. Cancer (1987) 0.95
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA (1987) 0.95
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer (1983) 0.94
Restoration and maintenance of glomerular filtration by mannitol during hypoperfusion of the kidney. J Clin Invest (1972) 0.94
Signet ring cell carcinoma of a pulled-through sigmoid colon mimicking a primary invasive bladder tumor: case report and review of the literature. Urology (2000) 0.94
Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists. Prostate Cancer Prostatic Dis (2011) 0.94
Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCC-NDI)? Am J Med Genet (1997) 0.93
Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function. Br J Haematol (2006) 0.93
Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med (2000) 0.93
Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy. Urology (1976) 0.93
Epithelioid leiomyoma of the bladder: an unusual cause of voiding symptoms. Urology (1998) 0.92
Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues. Prostate (1992) 0.92
The binding of antimalarial aminoquinolines to nucleic acids and polynucleotides. Mol Pharmacol (1970) 0.92
Histopathological effects of androgen deprivation in prostatic cancer. Semin Urol Oncol (1996) 0.92
Comparison of goserelin and leuprolide in combined androgen blockade therapy. Urology (1998) 0.91
The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int (2003) 0.91
Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents. Cancer Res (1973) 0.91
Dimensional reproduction in rotational panoramic radiography. Oral Surg Oral Med Oral Pathol (1986) 0.90
Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer. Cancer (1986) 0.90
The effect of viewing conditions on the perceptibility of radiographic details. Oral Surg Oral Med Oral Pathol (1983) 0.90
Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Qual Life Res (1992) 0.90
Regional lymphadenectomy and tumor immunity. Surg Gynecol Obstet (1976) 0.89
Side effects associated with intravesical mitomycin. J Urol (1981) 0.89
Early prostate cancer: prevention, treatment modalities, and quality of life issues. Eur Urol (2003) 0.89
Radical cystectomy and adjuvant chemotherapy. Urology (1985) 0.89
Cis-diamminedichloroplatinum II in advanced urothelial cancer. J Urol (1978) 0.89
Bladder neck preservation following radical prostatectomy: continence and margins. Eur Urol (1995) 0.89
Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer. Cancer (1981) 0.89
Urothelial dysplasia. J Urol (1982) 0.88
Real, double, and ghost images in rotational panoramic radiography. Dentomaxillofac Radiol (1983) 0.88
Absorption of 14 C-labeled 3-hydroxy-L-kynurenine and 3-hydroxyanthranilic acid from the mouse urinary bladder under carcinogenic conditions. Cancer Res (1965) 0.88
Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosourea. Urology (1983) 0.88
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer. J Urol (2001) 0.87
Image distortion in rotational panoramic radiography. IV. Object morphology; outer contours. Acta Radiol Diagn (Stockh) (1981) 0.87
Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide. Urology (1995) 0.87
Serial multiple-site biopsies in patients with bladder cancer. J Urol (1978) 0.86
Overview of treatment of superficial bladder cancer. Urology (1985) 0.86
Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy. Prostate Cancer Prostatic Dis (2010) 0.86
Developing carcinoma (dysplasia) of the urinary bladder. Pathol Annu (1982) 0.86
Fibroepithelial polyp of the renal pelvis: nephron-sparing surgery after false-positive biopsy for transitional cell carcinoma. Urology (1997) 0.85
Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study. Prostate Cancer Prostatic Dis (2007) 0.85
Value of urine cytology versus bladder washing in bladder cancer. Urology (1992) 0.85
Modified Pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience. Prostate Cancer Prostatic Dis (2007) 0.85
Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells. Acta Cytol (1979) 0.85
Porphyria turcica: hexachlorobenzene-induced porphyria. IARC Sci Publ (1986) 0.84
In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors. J Urol (1982) 0.84
Bilateral epidermoid cysts of the testis. Eur Urol (1996) 0.84
Synchronous and asynchronous carcinoma of the colon. Tex Med (1975) 0.84
Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer. J Urol (1998) 0.84
Hemospermia and expressed tumor in the urethra: an unusual presentation of ductal carcinoma of the prostate. J Urol (2000) 0.84